Medivo has announced the acquisition of OnTrack Diabetes, a free app that helps patients manage their diabetes by tracking health indicators like blood glucose levels, food intake, medications, blood pressure and weight, and creates reports to be shared with physicians.
The Android app currently has more than half a million users. Medivo also owns several other chronic disease management apps, including those targeted at Crohn's, hereditary angioedema and chronic myelogenous leukemia patients.
"We are extremely excited about adding the powerful OnTrack Diabetes app as a resource for patients to monitor their symptoms and to create reports that can be shared with their physician," said Sundeep Bhan, CEO and cofounder of Medivo, in the news release. "This acquisition also fits with our growth strategy, enhances our consumer app portfolio and furthers our plans to develop new patient and physician engagement services."
More Articles on mHealth:
Study: mHealth May Not Be As Effective in Promoting Physical Activity
The Hospital App Advantage: 5 Benefits of Going Mobile
Venture Capital Investment in mHealth Grows 35%